6% of eligible US individuals were screened for lung cancer in 2022, despite decades-long recommendations.
Lung cancer, the deadliest form of cancer, has low screening rates in the US, despite medical organizations recommending it for high-risk individuals for decades. In 2022, only 6% of eligible people were screened, falling behind screening rates for colon and breast cancers. Numerous complex barriers hinder widespread adoption of lung cancer screening, but early detection significantly improves survival rates.
May 07, 2024
4 Articles